Zdrowie i gospodarka · 14/06/1995

FDA Establishes Ad Hoc Advisory Committee on Creutzfeldt-Jakob Disease

The US Food and Drug Administration (FDA) has announced the creation of an Ad Hoc Advisory Committee on Creutzfeldt-Jakob Disease, which will be led by the Secretary of Health and Human Services, and will expire on June 9, 1996.